✦ LIBER ✦

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

✍ Scribed by Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; Naohito Yamamoto; Masafumi Kurosumi; Kenichi Inoue; Morihiko Kimura

Book ID: 111854248
Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 553 KB
Volume: 13
Category: Article
ISSN: 1340-6868
DOI: 10.2325/jbcs.13.166

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Weekly docetaxel and trastuzumab for her

Weekly docetaxel and trastuzumab for her-2-overexpressing metastatic breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study

✍ S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Phase II study of weekly docetaxel (Taxo

Phase II study of weekly docetaxel (Taxotere; txt) and trastuzumab (Herceptin; H) for patients with HER-2 overexpressing (HER2+) metastatic breast cancer (MBC)

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Phase II study of preoperative systemic

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Gemcitabine and Trastuzumab Combinations

Gemcitabine and Trastuzumab Combinations for Patients with Metastatic Breast Cancer Overexpressing HER2/neu

✍ Steven Stein; Angie DeMichele; Susan Domchek; Kevin Fox 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 112 KB

Multicenter phase II trial of three-week

Multicenter phase II trial of three-weekly docetaxel and weekly trastuzumab in HER-2-overexpressing metastatic breast cancer patients: Japan East cancer center breast cancer consortium (JECBC 01 trial)

✍ T Tabei; M Kimura; M Sano; T Asaga; J Ando; H Fujii; N Yamamoto; M Kurosumi; K I 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB